FTH1
Basic information
Region (hg38): 11:61959718-61967634
Previous symbols: [ "FTHL6" ]
Links
Phenotypes
GenCC
Source:
- hemochromatosis type 5 (Moderate), mode of inheritance: AD
- hemochromatosis type 5 (Supportive), mode of inheritance: AD
- hemochromatosis type 5 (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Hemochromatosis, type 5 | AD | Hematologic | Preventive measures to ameliorate iron overload may be beneficial | Hematologic; Neurologic | 11389486; 37660254 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FTH1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | |||||
missense | 14 | 15 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 15 | |||||
Total | 0 | 0 | 22 | 10 | 9 |
Variants in FTH1
This is a list of pathogenic ClinVar variants found in the FTH1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-61959791-A-G | Likely benign (May 20, 2021) | |||
11-61959869-CT-C | not provided (-) | |||
11-61959873-TTC-T | Likely benign (Jul 07, 2023) | |||
11-61959878-T-C | Likely benign (Aug 22, 2022) | |||
11-61959884-G-C | Likely benign (Sep 27, 2022) | |||
11-61959892-G-A | Autosomal recessive bestrophinopathy | Pathogenic (Jan 01, 2008) | ||
11-61959892-G-T | Autosomal recessive bestrophinopathy | Uncertain significance (Apr 23, 2020) | ||
11-61959896-C-A | Uncertain significance (Dec 13, 2019) | |||
11-61959897-C-G | Vitelliform macular dystrophy 2 • Retinitis pigmentosa • Autosomal dominant vitreoretinochoroidopathy | Conflicting classifications of pathogenicity (Nov 27, 2023) | ||
11-61959899-T-C | Autosomal recessive bestrophinopathy • Retinal dystrophy | Likely pathogenic (Jan 01, 2022) | ||
11-61959906-T-C | Likely benign (Feb 10, 2023) | |||
11-61959909-GGATGA-G | BEST1-related disorder | Pathogenic (Jan 24, 2024) | ||
11-61959911-A-T | Vitelliform macular dystrophy 2 • Retinal dystrophy | Uncertain significance (Apr 08, 2021) | ||
11-61959912-T-A | Vitelliform macular dystrophy 2 | Uncertain significance (Dec 05, 2019) | ||
11-61959913-G-T | Pathogenic (Nov 13, 2023) | |||
11-61959917-T-C | Vitelliform macular dystrophy 2 • BEST1-related disorder | Conflicting classifications of pathogenicity (Jul 14, 2022) | ||
11-61959929-T-C | Uncertain significance (Sep 27, 2022) | |||
11-61959934-C-T | Autosomal dominant vitreoretinochoroidopathy • Vitelliform macular dystrophy 2 • Retinitis pigmentosa | Conflicting classifications of pathogenicity (Nov 01, 2022) | ||
11-61959935-G-A | Retinal dystrophy • BEST1-related disorder | Conflicting classifications of pathogenicity (Nov 27, 2023) | ||
11-61959935-G-C | Uncertain significance (Feb 04, 2022) | |||
11-61959936-GA-G | Pathogenic (Aug 23, 2022) | |||
11-61959944-C-T | Uncertain significance (Oct 24, 2020) | |||
11-61959945-G-A | Likely benign (Nov 29, 2023) | |||
11-61959949-A-G | Inborn genetic diseases | Uncertain significance (Sep 29, 2023) | ||
11-61959950-T-G | Uncertain significance (Jan 29, 2014) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FTH1 | protein_coding | protein_coding | ENST00000273550 | 4 | 7943 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.140 | 0.842 | 124788 | 0 | 7 | 124795 | 0.0000280 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.865 | 72 | 95.8 | 0.751 | 0.00000518 | 1212 |
Missense in Polyphen | 4 | 11.014 | 0.36318 | 183 | ||
Synonymous | -0.879 | 49 | 41.8 | 1.17 | 0.00000240 | 324 |
Loss of Function | 2.05 | 3 | 9.98 | 0.301 | 5.93e-7 | 110 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.0000993 | 0.0000993 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000545 | 0.0000530 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Stores iron in a soluble, non-toxic, readily available form. Important for iron homeostasis. Has ferroxidase activity. Iron is taken up in the ferrous form and deposited as ferric hydroxides after oxidation. Also plays a role in delivery of iron to cells. Mediates iron uptake in capsule cells of the developing kidney (By similarity). {ECO:0000250}.;
- Pathway
- Necroptosis - Homo sapiens (human);Mineral absorption - Homo sapiens (human);Ferroptosis - Homo sapiens (human);Iron metabolism in placenta;Nuclear Receptors Meta-Pathway;NRF2 pathway;Golgi Associated Vesicle Biogenesis;Clathrin derived vesicle budding;Neutrophil degranulation;trans-Golgi Network Vesicle Budding;Vesicle-mediated transport;Membrane Trafficking;Innate Immune System;Immune System;Transport of small molecules;Methionine and cysteine metabolism;Iron uptake and transport;Binding and Uptake of Ligands by Scavenger Receptors;Scavenging by Class A Receptors;Validated targets of C-MYC transcriptional repression
(Consensus)
Recessive Scores
- pRec
- 0.485
Intolerance Scores
- loftool
- 0.169
- rvis_EVS
- 0.1
- rvis_percentile_EVS
- 61.28
Haploinsufficiency Scores
- pHI
- hipred
- Y
- hipred_score
- 0.669
- ghis
- 0.442
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.976
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fth1
- Phenotype
- immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); liver/biliary system phenotype; cellular phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- cellular iron ion homeostasis;intracellular sequestering of iron ion;immune response;negative regulation of cell population proliferation;neutrophil degranulation;negative regulation of fibroblast proliferation;oxidation-reduction process;negative regulation of necrotic cell death
- Cellular component
- extracellular region;nucleus;cytoplasm;cytosol;intracellular ferritin complex;autolysosome;extracellular exosome;tertiary granule lumen;ficolin-1-rich granule lumen
- Molecular function
- ferroxidase activity;iron ion binding;protein binding;ferrous iron binding;ferric iron binding;identical protein binding